Therefore, the System Xc-GSH-GPX4 axis plays a crucial role in the progression of renal cancer and may represent a novel strategy for utilizing ferroptosis therapy in advanced renal cancer and even drug-resistant renal cancer in the future. This evidence concerns the gene GPX4 and renal carcinoma.